Clinical Trial Update: BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer [Phase 2]

View source ↗

Summary

This document describes a Phase 2 clinical trial (NCT06441890) evaluating biomarker-driven optimization of neoadjuvant therapy for breast cancer, including HER2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Breast Cancer, HER2-positive Breast Cancer | Phase 2 | Status: RECRUITING